# Dillard'S, Inc.: overview

DDS · TXSE · CIK 28917 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Jan 30

Pages: [Overview](/companies/dds.md) · [Financials](/companies/dds/financials.md) · [Filings](/companies/dds/filings.md) · [Insiders](/companies/dds/insiders.md)

Latest reported revenue: [$1.51bn](/filings/0000028917-26-000027.md) for Q2 FY2026, three months to 2026-08-01, from the 10-Q filed Sep 4, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0000028917-26-000027).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-11-02) | Q4 FY2024 (2025-02-01) | Q1 FY2025 (2025-05-03) | Q2 FY2025 (2025-08-02) | Q3 FY2025 (2025-11-01) | Q4 FY2025 (2026-01-31) | Q1 FY2026 (2026-05-02) | Q2 FY2026 (2026-08-01) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,427](/filings/0000028917-25-000032.md) | [2,017 d](/filings/0000028917-26-000006.md) | [1,529](/filings/0000028917-26-000019.md) | [1,514](/filings/0000028917-26-000027.md) | [1,469](/filings/0000028917-25-000032.md) | [1,962 d](/filings/0000028917-26-000006.md) | [1,568](/filings/0000028917-26-000019.md) | [1,508](/filings/0000028917-26-000027.md) |
| Gross margin | % | [42.6%](/filings/0000028917-25-000032.md) | [34.9% d](/filings/0000028917-26-000006.md) | [43.9%](/filings/0000028917-26-000019.md) | [36.6%](/filings/0000028917-26-000027.md) | [43.4%](/filings/0000028917-25-000032.md) | [35.4% d](/filings/0000028917-26-000006.md) | [44.5%](/filings/0000028917-26-000019.md) | [39.7%](/filings/0000028917-26-000027.md) |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [8.7%](/filings/0000028917-25-000032.md) | [10.6% d](/filings/0000028917-26-000006.md) | [10.7%](/filings/0000028917-26-000019.md) | [4.8%](/filings/0000028917-26-000027.md) | [8.8%](/filings/0000028917-25-000032.md) | [10.4% d](/filings/0000028917-26-000006.md) | [16.0%](/filings/0000028917-26-000019.md) | [6.5%](/filings/0000028917-26-000027.md) |
| Diluted EPS | $ per share | [7.73](/filings/0000028917-25-000032.md) | not reported | [10.39](/filings/0000028917-26-000019.md) | [4.66](/filings/0000028917-26-000027.md) | [8.31](/filings/0000028917-25-000032.md) | not reported | [16.04](/filings/0000028917-26-000019.md) | [6.25](/filings/0000028917-26-000027.md) |
| Free cash flow | $m | [145 d](/filings/0000028917-25-000032.md) | [349 d](/filings/0000028917-26-000006.md) | [216](/filings/0000028917-26-000019.md) | [60.1 d](/filings/0000028917-26-000027.md) | [156 d](/filings/0000028917-25-000032.md) | [192 d](/filings/0000028917-26-000006.md) | [347](/filings/0000028917-26-000019.md) | [(59.5) d](/filings/0000028917-26-000027.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2022-01-29) | FY2022 (2023-01-28) | FY2023 (2024-02-03) | FY2024 (2025-02-01) | FY2025 (2026-01-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [6,493](/filings/0000028917-24-000011.md) | [6,871](/filings/0000028917-25-000004.md) | [6,752](/filings/0000028917-26-000006.md) | [6,483](/filings/0000028917-26-000006.md) | [6,474](/filings/0000028917-26-000006.md) |
| Gross margin | % | [42.3%](/filings/0000028917-24-000011.md) | [42.0%](/filings/0000028917-25-000004.md) | [40.3%](/filings/0000028917-26-000006.md) | [39.5%](/filings/0000028917-26-000006.md) | [39.5%](/filings/0000028917-26-000006.md) |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [13.3%](/filings/0000028917-24-000011.md) | [13.0%](/filings/0000028917-25-000004.md) | [10.9%](/filings/0000028917-26-000006.md) | [9.2%](/filings/0000028917-26-000006.md) | [8.8%](/filings/0000028917-26-000006.md) |
| Diluted EPS | $ per share | [41.88](/filings/0000028917-24-000011.md) | [50.81](/filings/0000028917-25-000004.md) | [44.73](/filings/0000028917-26-000006.md) | [36.82](/filings/0000028917-26-000006.md) | [36.42](/filings/0000028917-26-000006.md) |
| Free cash flow | $m | [1,176](/filings/0000028917-24-000011.md) | [828](/filings/0000028917-25-000004.md) | [751](/filings/0000028917-26-000006.md) | [610](/filings/0000028917-26-000006.md) | [624](/filings/0000028917-26-000006.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/dds/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [Newport Trust Company, LLC](/funds/1722329.md) | 2026-06-30 | $2.36bn | 4,472,875 |  | Reduced −39,302 |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $115.4m | 218,316 |  | Added +30,143 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $113.6m | 214,974 |  | Reduced −1,111 |
| [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $100.7m | 190,636 |  | Added +23,929 |
| [Allianz Asset Management GmbH](/funds/1535323.md) | 2026-06-30 | $85.8m | 162,415 |  | Added +1,530 |
| [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $85.4m | 161,539 |  | Added +19,359 |
| [AQR CAPITAL MANAGEMENT LLC](/funds/1167557.md) | 2026-06-30 | $84.4m | 159,685 |  | Added +34,193 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $82.7m | 156,478 |  | Added +7,376 |
| [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $79.2m | 149,934 |  | Added +5,175 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $70.0m | 132,562 |  | Added +718 |

## Recent filings

[All 3,824 filings](/companies/dds/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-18 | 16:15 ET | [8-K](/filings/0001104659-26-108945.md) | 3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-108945 |
| 2026-09-04 | 16:06 ET | [10-Q](/filings/0000028917-26-000027.md) | Quarterly report, period 2026-08-01 | 0000028917-26-000027 |
| 2026-08-13 | 16:11 ET | [8-K](/filings/0000028917-26-000024.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000028917-26-000024 |
| 2026-06-05 | 16:16 ET | [10-Q](/filings/0000028917-26-000019.md) | Quarterly report, period 2026-05-02 | 0000028917-26-000019 |
| 2026-06-05 | 06:31 ET | [SCHEDULE 13D](/filings/0001104659-26-070708.md) | Ownership report, active investor | 0001104659-26-070708 |
| 2026-06-04 | 16:15 ET | [8-K](/filings/0001104659-26-070529.md) | 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001104659-26-070529 |
| 2026-06-01 | 16:13 ET | [8-K](/filings/0000028917-26-000015.md) | 5.07 Shareholder vote results | 0000028917-26-000015 |
| 2026-05-14 | 16:32 ET | [8-K](/filings/0000028917-26-000009.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000028917-26-000009 |
| 2026-03-27 | 16:43 ET | [10-K](/filings/0000028917-26-000006.md) | Annual report, period 2026-01-31 | 0000028917-26-000006 |
| 2026-03-20 | 16:30 ET | [8-K](/filings/0001104659-26-032749.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001104659-26-032749 |

## Latest annual report

[Form 10-K for the fiscal year ended Jan 31, 2026](/filings/0000028917-26-000006.md), filed Mar 27, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 28917
- Tickers: DDS, DDT
- Exchange: TXSE
- SIC code: 5311 Retail-Department Stores
- State of incorporation: TX
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 27, 2026, 18:21 ET. No prices; not investment advice.